Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Orbis Global Equity Fund Brent Jackson | “Take insurance brokerage. Brown & Brown and Ryan Specialty are brokers: they sit between companies and insurers, matching clients to the right coverage and placing it for a fee, without carrying the risk themselves. Both are priced as AI casualties. Two fears weigh on the stocks: a softening pricing cycle and AI disintermediation. The pricing cycle is already in the price. On AI, we disagree. AI may automate commodity cover like personal auto, but that is under 5% of Brown & Brown's book. The rest is commercial and specialty insurance, where the broker exercises judgement and answers for a denied claim. It is a people business, and Brown & Brown has spent more than eighty years serving mid-sized companies that lack the in-house expertise in insurance.” | NEUTRAL | Q2 2026 Jul 30, 2026 | View Pitch |
REQ Global Compounders Oddbjørn Dybvad | “The share price of the US insurance broker Brown & Brown fell 21% in 2025 despite growth in operating cash flow of 24% during the first nine months. We believe the main reasons for the decline are the wait-and-see attitude toward the outcome of the largest acquisition in the company's history and weaker-than-normal trading due to market conditions. The acquisition of Accession is large relative to historical deals and has raised investor skepticism. Importantly, there is nothing wrong with cash generation at Brown & Brown. The company increased its dividend by 15%, marking the 32nd consecutive year of increases. BSD Analysis: Brown & Brown is one of the most consistent performers in insurance brokerage, thriving on steady rate increases and relentless execution. Its decentralized culture keeps local producers motivated while benefiting from scale economics. The company avoids underwriting risk, focusing instead on commissions and fees. M&A remains disciplined, targeting cultural fit over size. Rising premiums directly lift revenue without incremental risk. Margins and cash flow are remarkably stable. Brown & Brown is a low-drama, high-quality compounder in financial services.” | BULL | Q4 2025 Dec 31, 2025 | View Pitch |
Fenimore Value Strategy John Fox | “Brown & Brown continues to compound earnings through organic growth, disciplined acquisitions, and strong retention. Pricing conditions in commercial insurance remain favorable, supporting commission growth. The company's decentralized culture enables entrepreneurial growth while maintaining cost discipline. Consistent free cash flow supports ongoing M&A. Shares are viewed as fairly valued given durability and long-term growth prospects. BSD Analysis: Brown & Brown is an insurance brokerage compounder built on distribution density and relentless execution. The moat is client stickiness plus carrier relationships that improve placement economics. Organic growth is steady, and acquisitions extend reach without cultural blowups—usually. Exposure to insurance pricing cycles is a feature, not a bug, when discipline holds. The risk is overpaying for acquisitions as competition for brokers heats up. Margins are resilient because commissions reset annually. The bull case is continued consolidation and pricing tailwinds. Brown & Brown earns its multiple by staying boring and profitable.” | BULL | Q4 2025 Dec 31, 2025 | View Pitch |
BBH Select Series - Mid Cap Fund Timothy F. Harris | “This leading P&C insurance broker is demonstrating robust performance, driven by exceptional organic growth and margin expansion. Its specialized Programs division has shown standout strength, while international expansions provide additional growth runways.” | BULL | Q1 2025 Mar 31, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
